Search results

This NICE resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

Home News Articles {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/"

Home News...

Health inequalities are differences in health across the population, and between different groups in society, that are systematic, unfair and avoidable.

Evidence-based recommendations on epiretinal brachytherapy for wet age related macular degeneration. This involves using radiation therapy used to destroy the new blood vessels.

Result type

HealthTech guidance

Published

16 December 2011

Find out which guidance and quality standards are awaiting development

View a complete list of all our guidance, NICE advice and quality standards currently in development

Subscribe to NICE newsletters and alerts for the latest healthcare guidance, clinical updates, and evidence-based resources across health and social care.

Outside interests of the NICE board

Evidence-based recommendations on irreversible electroporation for treating pancreatic cancer. This involves inserting special needles into the tumour in the pancreas and using short electrical pulses to destroy the cancer cells.

Result type

HealthTech guidance

Published

3 May 2017

Evidence-based recommendations on epiduroscopic lumbar discectomy through the sacral hiatus for sciatica in adults. This involves removing the part of the spinal disc pressing against the spinal nerve, to relieve pain.

Result type

HealthTech guidance

Published

14 December 2016

Evidence-based recommendations on angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunction in adults. This involves using a device to improve blood flow to the penis.

Result type

HealthTech guidance

Published

24 February 2016

Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.

Result type

HealthTech guidance

Published

10 July 2019

Evidence-based recommendations on epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer. This involves radioactive paste being spread on foil over the top of the cancer, to destroy the cancer cells.

Result type

HealthTech guidance

Published

2 April 2024

NICE International enquiry form